Arginase II: atherogenesis beyond enzyme activity.
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Deepesh
D
Pandey
Lewis
L
Romer
Dan E
DE
Berkowitz
D000818:Animals; D017209:Apoptosis; D001119:Arginase / Q000378:metabolism*; D050197:Atherosclerosis / Q000201:enzymology*; D016922:Cellular Senescence; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000201:enzymology*; D032389:Myocytes, Smooth Muscle / Q000201:enzymology*; D058226:Plaque, Atherosclerotic; D055765:Shc Signaling Adaptor Proteins / Q000378:metabolism*; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
C528024:SHC1 protein, human; D055765:Shc Signaling Adaptor Proteins; C528034:Shc1 protein, mouse; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C477631:ARG2 protein, human; C481673:Arg2 protein, mouse; D001119:Arginase
Editorial; S6K1; arginase II; atherosclerosis; mitochondria; p53; p66SHC; vascular smooth muscle cells